Below are excerpts from an electronic FDA newsletter dated 8/18/10 which may be of interest. You can subscribe to this through the FDA website:
http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/GetEmailUpdates/default.htm
Safe Use of Long-Acting Beta-Agonists (July 16)
FDA Drug Info Rounds pharmacists discuss the new recommendations in the drug labels of Long-Acting Beta-Agonists (LABAs), and provide ways pharmacists can help patients use LABAs safely in the treatment of asthma.
FDA Issues Assessments of the 510(k) Program and Use of Science in Decision-Making (Aug 4)
The FDA issued two comprehensive evaluations containing recommendations that address three key objectives of the agency’s public health mission as it relates to medical devices – foster device innovation, create a more predictable regulatory environment, and enhance device safety.